Observational studyFuture oncology (London, England)2025

Long-term safety and effectiveness of ruxolitinib in patients with myelofibrosis in Japan: an observational study.

Yusuke Aruga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.